Clinical Trials in Philadelphia

Showing 1561-1580 of 17,926 trials

REALITY LHON Registry

NCT03295071

This study is a multi-country retrospective and cross-sectional observational study of affected LHON subjects, based on retrospective subjects' medical chart abstractions and cross-sectional administration of patient-reported outcomes (PROs).

Leber Hereditary Optic Neuropathy

GenSight Biologics44 participantsStarted Jan 2018

Pasadena, California, United States • Atlanta, Georgia, United States • Boston, Massachusetts, United States +8 more locations

COMPLETEDPhase 1/2< 1 mile

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

NCT04238819

The study's purpose is to see if the drug, abemaciclib, is safe and effective when given with other drugs to kill cancer cells. The study is open to children and young adults with solid tumors, including neuroblastoma, that did not respond or grew during other anti-cancer treatment. For each participant, the study is estimated to last up to 2 years.

Relapsed Solid TumorRefractory Solid Tumor

Eli Lilly and Company47 participantsStarted Nov 2020

Phoenix, Arizona, United States • Los Angeles, California, United States • Oakland, California, United States +22 more locations

REALITY LHON Registry

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Find Trials by Condition in Philadelphia

Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST)

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Mobile Health for Adherence in Breast Cancer Patients

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults

A Study of LY4175408 in Participants With Advanced Cancer

A Study of ASP3082 in Adults With Advanced Solid Tumors

A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708

Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

QTX3544 in Patients With Advanced Solid Tumors With KRAS G12V Mutations

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors